http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2015343061-A1

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_21dd0e090a3c11b14df0ced94f534c9d
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-4184
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D235-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-20
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P13-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-0019
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-4184
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-20
filingDate 2015-08-06-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_613320de3930371987d0da0f6b94e0fa
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_9303e691ad2551764f96a55de1f11db5
publicationDate 2015-12-03-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber US-2015343061-A1
titleOfInvention Method of treating bendamustine-responsive conditions in patients requiring reduced volumes for administration
abstract Methods of treating bendamustine responsive conditions in patients having fluid and/or sodium intake restrictions are disclosed. The methods include identifying patients having such restrictions and in need of bendamustine, and then administering thereto a bendamustine-containing composition in a volume of about 120 ml or less intravenously over a period of about 15 minutes or less. The smaller volumes and reduced sodium load as compared to currently known methods of treatment minimize cardiac and/or renal stress in patients having diseases such as congestive heart failure or renal disease.
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2016000759-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2016144034-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2016144035-A1
priorityDate 2012-03-20-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID77082
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID24749
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226408765
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID65628
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226414200
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226394438

Total number of triples: 33.